INTRODUCTION
============

Enterotoxigenic *Bacteroides fragilis* (ETBF) is an intestinal bacteria that has been associated with inflammatory bowel disease and colorectal cancer in humans ([@B1],[@B2]). ETBF also cause diarrhea and colitis in both livestock and laboratory animals ([@B3]-[@B7]). In the Min mouse model, ETBF promotes colonic tumorigenesis via the Th17/IL-23 pathway ([@B8]). The only known virulence factor specific for ETBF is the secreted 20 kDa metalloprotease called *B. fragilis* toxin (BFT) ([@B9],[@B10]). Addition of purified BFT to colonic epithelial cell lines induces several distinct changes. These include ectodomain cleavage of E-cadherin, morphological \"rounding\" of cells and secretion of IL-8 ([@B11]-[@B14]). E-cadherin is a 120 kDa type I transmembrane protein essential to the formation of intercellular adhesion of adjacent epithelial cells ([@B15]). The cytoplasmic domain of E-cadherin is bound to β-catenin, which in turn associates with α-catenin and cytoskeletal actin ([@B16]). These associations result in formation of a stable epithelial monolayer which provides a protection barrier against infiltration of external insults. The loss of this epithelial integrity results in inflammatory disorders including colitis. BFT induces rapid cleavage of the extracellular domain of E-cadherin which result in cell rounding and loss of epithelial integrity. Subsequent E-cadherin degradation by γ-secretase releases the bound β-catenin and nuclear translocation of β-catenin activates the β-catenin-TCF-dependent pathway ([@B17]).

To date, several cytokines and chemokines have been identified to be secreted in response to BFT treatment of intestinal epithelial cells: TGF-β, ENA-78, GRO-α, MCP-1 and IL-8 ([@B13],[@B14],[@B18]). IL-8 is a potent inflammatory chemokine that is quickly secreted in response to microbial insults and functions to recruit neutrophils to sites of damage. IL-8 induction can occur through activation of the NF-κB and MAPK pathways. Using hepatoma cells, Levy et al. found that stimulation of the β-catenin pathway induces expression of IL-8 due to the presence of a unique consensus Tcf/Lef site that is critical for IL-8 activation by β-catenin ([@B19]). Taken together, we propose a model for BFT-induced IL-8 secretion in which the enzymatically active BFT induces E-cadherin degradation, which results in release of the bound β-catenin that in turn translocate into the nucleus and actives IL-8 expression. In this study, we present data suggesting that activation of the β-catenin pathway in the colonic epithelial cell line by disruption of the E-cadherin junction is sufficient to induce IL-8 secretion.

MATERIALS AND METHODS
=====================

Cell culture and reagents
-------------------------

The human colonic epithelial cells line (HT29/C1) was originally obtained from Dr. Daniel Louvard, Institut Pasteur, Paris, France). HEK293/17 cells were purchased from ATCC. Cells were cultured in 10% FBS-DMEM containing gentamicin (100 ug/ml) and penicillin/streptomycin. All cell culture reagents were purchased from GIBCO BRL Life Technologies (Rockville, MD, USA). Cells were grown to subconfluent monolayers (\~70%) in 6-well plates. The cells were then washed with serum-free DMEM three times and then cultured with 3 ml of serum-free DMEM containing purified BFT (100 ng/ml), EDTA (Sigma-Aldrich, USA), NaCl (Sigma-Aldrich, USA), LiCl (Sigma-Aldrich, USA), DSS (MW 30,000\~45,000; MP Biochemicals, USA), 0.05% trypsin solution (Gibco, USA) or recombinant human IL-1β (50 ng/ml)(R&D Systems, USA) for 24 hr. To induce physical damage to cells, the subconfluent monolayer was scratched full length with a 1 ml pipette tip either 5 or 20 times.

IL-8 ELISA and Western blot analysis
------------------------------------

For IL-8 ELISA, cell culture supernatants were harvested, clarified by centrifugation and stored at -20℃ until analyzed by an IL-8 ELISA kit (R&D Systems, USA). Western blot analysis was performed as previously described ([@B4]). In brief, cells were washed two times with ice-cold PBS and lysed on ice for 15 min in RIPA buffer (Sigma-Aldrich, USA) containing protease inhibitors (Roche, USA). Clarified lysates were stored at -20℃ until analyzed by Western blot analysis using monoclonal antibodies against the extracellular domain of E-cadherin (H108, Santa Cruz Biotechnology, USA) or β-actin (Sigma-Aldrich, USA). Lysates were electrophoresed under reducing conditions on 12% SDS-PAGE gels and then transferred to 0.22-µm nitrocellulose membranes. Appropriate HRP-conjugated secondary antibodies and SuperSignal West Pico chemiluminescent substrates (Pierce, USA) were used to develop the bands on X-ray film.

Data analysis
-------------

Statistical analysis and graphic presentation were performed using GraphPad Prism 5. p-values were calculated using Anova. Values are shown as mean and standard error of mean (SEM). Data were collected from 3\~5 independent experiments. A p-value\<0.05 was considered statistically significant.

RESULTS AND DISCUSSION
======================

As previously reported, BFT induces IL-8 secretion in the colonic epithelial cell line HT29/C1 which expresses E-cadherin ([Fig. 1A](#F1){ref-type="fig"}). The induction of IL-8 secretion is considered to be due to cleavage of E-cadherin which releases the intracellular bound β-catenin leading to IL-8 secretion. Cells that do not express E-cadherin such as HEK293/17 cells do not secrete IL-8 in response to BFT treatment although these cells do have the capacity to release potent levels of IL-8 in response to inflammatory cytokine stimulation such as IL-β ([Fig. 1A](#F1){ref-type="fig"}). These results as well as results from other studies suggest that induction of IL-8 by BFT requires E-cadherin cleavage ([@B4]). If induction of IL-8 is due to disruption of the E-cadherin junction by BFT mediated cleavage of E-cadherin, then enzymatic cleavage of the E-cadherin ectodomain by other enzymes should also induce IL-8. To test this hypothesis, HT29/C1 cells were treated with dilute trypsin for 24 hr and the supernatant assessed for IL-8 secretion by ELISA. We found that trypsin treated HT29/C1 cells showed a dramatic loss of the full length 120 kDa E-cadherin protein and become refractile indicating a loss of cell-to-cell contact (data not shown). In trypsin treated cells, IL-8 secretion was induced in a trypsin concentration dependent manner suggesting that E-cadherin cleavage resulted in IL-8 induction ([Fig. 1B](#F1){ref-type="fig"}). Physical damage of the cellular monolayer was insufficient to induce IL-8 secretion as scratching the subconfluent monolayers with a sterile pipette tip either 5 times or 20 times did not induce IL-8 secretion ([Fig. 1B](#F1){ref-type="fig"}).

The results from the BFT treatment and trypsin treatment strongly suggest that cleavage of E-cadherin is the underlying reason for IL-8 induction. Homophilic E-cadherin interactions between adjacent epithelial cells require the presence of calcium to mediate a stable interaction. Addition of the calcium-chelating EDTA is known to disrupt this interaction without inducing E-cadherin cleavage. We examined if disruption of the E-cadherin homophilic interaction was sufficient to induce IL-8 addition. HT29/C1 cells were treated with different doses of EDTA (0, 1, 2.5, 5 mM) for 24 hr and the secreted IL-8 examined by ELISA. We found an EDTA dose-dependent increase in IL-8 secretion ([Fig. 2A](#F2){ref-type="fig"}). The addition of EDTA did not change any noticeable changes in protein levels of the full length E-cadherin and no evidence of E-cadherin cleavage as determined by Western blot analysis ([Fig. 2B](#F2){ref-type="fig"}). Similarly, we found that physical damage of the HT29/C1 cell monolayer using a pipette tip did not induce E-cadherin cleavage ([Fig. 2B](#F2){ref-type="fig"}). These results suggest that disruption of E-cadherin interaction without E-cadherin cleavage is sufficient to induce IL-8 secretion.

The promoter of the IL-8 gene contains a binding site for the β-catenin/TCF complex ([@B19]). This observation suggests that activation of the β-catenin pathway may be sufficient to induce IL-8 secretion in HT29/C1 cells. To determine if HT29/C1 cells can secrete IL-8 through activation of the β-catenin pathway, we treated HT29/C1 cells with LiCl which is known to stimulate the β-catenin pathway ([@B19],[@B20]). HT29/C1 cells were treated with different concentrations of LiCl for 24 hr and IL-8 secretion determined by ELISA. We found a LiCl dose-dependent increase in IL-8 secretion beginning at 10 mM which then peaked at 50 mM. At 100 mM LiCl, IL-8 secreted was completely inhibited to background levels suggesting an optimal dose of 50 mM ([Fig. 3A](#F3){ref-type="fig"}). Equal concentrations of NaCl served as a control for LiCl treatment which did not induce IL-8 secretion at all concentrations used ([Fig. 3A](#F3){ref-type="fig"}). Next, we conducted a time course experiment with LiCl by treating HT29/C1 cells with 50 mM LiCl for 2, 4, 6 or 8 hrs and measured IL-8 by ELISA. We found an increase in IL-8 secretion beginning at 2 hr post-treatment and thereafter gradually increased over time ([Fig. 3B](#F3){ref-type="fig"}). These results suggest that activation of the β-catenin pathway is sufficient to induce IL-8 secretion in the HT29/C1 cell line.

ETBF has been suggested to contribute to development of colon cancers ([@B8]). Considering that IL-8 expression correlates with induction and progression of colorectal cancer, it would be important to understand the precise mechanism by which BFT induces IL-8 secretion ([@B21]). Taken together, our results suggest that in the HT29/C1 cell line, BFT induces IL-8 secretion by disruption of E-cadherin junctions and changes in cellular contacts which then lead to activation of the β-catenin pathway. BFT is known to induce E-cadherin cleavage and IL-8 secretion. However, it is not clear if E-cadherin cleavage is required for IL-8 secretion. Our data, raise the possibility that E-cadherin disruption and therefore cell-cell dissociation is sufficient to induce IL-8 secretion. We suggest that E-cadherin cleavage per se may not be required for BFT induced IL-8 secretion.
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![Induction of IL-8 secretion by various stimuli. (A) HT29/C1 cells or HEK293/17 cells were cultured with BFT (100 ng/ml) or IL-1β (50 ng/ml) for 24 hr and IL-8 secretion assessed by ELISA. (B) HT29/C1 cells were cultured with diluted trypsin solution (1/100, 1/1,000) or dextran sulfate sodium (DSS) for 24 hr and IL-8 secretion assessed by ELISA. To induce physical damage, the subconfluent cell monolayer was scratched in a line with a pipette tip either 5 or 20 times. Asterisks indicate p\<0.05. Data are shown as mean and SEM.](in-13-213-g001){#F1}

![Disruption of E-cadherin interaction but not physical damage induces IL-8 secretion. Subconfluent HT29/C1 cells were cultured with EDTA, scratched (20 times) or treated with purified BFT (100 ng/ml) for 24 hr. (A) IL-8 secretion. (B) Western blot analysis of E-cadherin and β-actin. Cells were treated with Asterisks indicate p\<0.05. Data are shown as mean and SEM.](in-13-213-g002){#F2}

![LiCl treatment induces IL-8 secretion in HT29/C1 cells. Cells were cultured with (A) different concentrations of LiCl for 24 hr or (B) different lengths of time with 50 mM of LiCl. IL-8 secretion was assessed by ELISA. Asterisks indicate p\<0.05. Data are shown as mean and SEM.](in-13-213-g003){#F3}
